Humaid Al-Shamsi, Chairman of Nexomic, Chief Executive Officer of Burjeel Cancer Institute (BCI), Honorary Professor at Gulf Medical University, Visiting Professor at Harvard Medical School, and Visiting Scientist at Dana-Farber Cancer Institute, shared on LinkedIn:
“Week 35 of 2026 — and my 35th scientific publication of the year.
We are grateful to maintain an average of one scientific publication every week throughout 2026.
This international study was conducted in collaboration with colleagues from India, the United States and the United Kingdom, and, where we presented novel technologies developed by our team Datar Cancer Genetics Limited using artificial intelligence for the early detection of cancer.
Humbled to be the most publishing oncologist in the MENA region and to continue contributing to science, innovation, and the global fight against cancer.”
Other posts featuring Humaid Al-Shamsi on OncoDaily.